nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Perindopril—coronary artery disease	0.349	0.547	CbGbCtD
Cyclopentolate—BCHE—Ramipril—coronary artery disease	0.289	0.453	CbGbCtD
Cyclopentolate—Conjunctivitis allergic—Timolol—coronary artery disease	0.0079	0.0393	CcSEcCtD
Cyclopentolate—Punctate keratitis—Timolol—coronary artery disease	0.00483	0.0241	CcSEcCtD
Cyclopentolate—Hyperaemia—Timolol—coronary artery disease	0.00404	0.0201	CcSEcCtD
Cyclopentolate—Intraocular pressure increased—Enalapril—coronary artery disease	0.00379	0.0189	CcSEcCtD
Cyclopentolate—Lacrimation—Enalapril—coronary artery disease	0.00284	0.0141	CcSEcCtD
Cyclopentolate—Lacrimation—Perindopril—coronary artery disease	0.00264	0.0132	CcSEcCtD
Cyclopentolate—Ocular hyperaemia—Timolol—coronary artery disease	0.0026	0.013	CcSEcCtD
Cyclopentolate—Disorientation—Penbutolol—coronary artery disease	0.0026	0.013	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Fenofibrate—coronary artery disease	0.00238	0.0118	CcSEcCtD
Cyclopentolate—Vasodilation—Fenofibrate—coronary artery disease	0.00238	0.0118	CcSEcCtD
Cyclopentolate—Coma—Acetylsalicylic acid—coronary artery disease	0.00214	0.0106	CcSEcCtD
Cyclopentolate—Lacrimation—Timolol—coronary artery disease	0.00208	0.0103	CcSEcCtD
Cyclopentolate—Gastroenteritis—Rosuvastatin—coronary artery disease	0.00197	0.00981	CcSEcCtD
Cyclopentolate—Lacrimation increased—Enalapril—coronary artery disease	0.00181	0.00901	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Perindopril—coronary artery disease	0.00177	0.0088	CcSEcCtD
Cyclopentolate—Vasodilation—Perindopril—coronary artery disease	0.00177	0.0088	CcSEcCtD
Cyclopentolate—Gastroenteritis—Fenofibrate—coronary artery disease	0.00171	0.00852	CcSEcCtD
Cyclopentolate—Lacrimation increased—Perindopril—coronary artery disease	0.00169	0.00839	CcSEcCtD
Cyclopentolate—Gastroenteritis—Olmesartan—coronary artery disease	0.00147	0.00731	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Timolol—coronary artery disease	0.00139	0.00692	CcSEcCtD
Cyclopentolate—Vasodilation—Timolol—coronary artery disease	0.00139	0.00692	CcSEcCtD
Cyclopentolate—Hyperkinesia—Perindopril—coronary artery disease	0.00135	0.00675	CcSEcCtD
Cyclopentolate—Gastroenteritis—Telmisartan—coronary artery disease	0.00135	0.00671	CcSEcCtD
Cyclopentolate—Lacrimation increased—Timolol—coronary artery disease	0.00133	0.0066	CcSEcCtD
Cyclopentolate—Drowsiness—Acetylsalicylic acid—coronary artery disease	0.00131	0.00651	CcSEcCtD
Cyclopentolate—Abdominal distension—Clopidogrel—coronary artery disease	0.0013	0.00646	CcSEcCtD
Cyclopentolate—Gastroenteritis—Perindopril—coronary artery disease	0.00127	0.00633	CcSEcCtD
Cyclopentolate—Urinary retention—Niacin—coronary artery disease	0.00121	0.00602	CcSEcCtD
Cyclopentolate—Photophobia—Timolol—coronary artery disease	0.00115	0.00571	CcSEcCtD
Cyclopentolate—Ataxia—Enalapril—coronary artery disease	0.00114	0.00567	CcSEcCtD
Cyclopentolate—Conjunctivitis—Fenofibrate—coronary artery disease	0.00114	0.00565	CcSEcCtD
Cyclopentolate—Vision blurred—Gemfibrozil—coronary artery disease	0.00113	0.00561	CcSEcCtD
Cyclopentolate—Conjunctivitis—Clopidogrel—coronary artery disease	0.00112	0.00556	CcSEcCtD
Cyclopentolate—Abdominal distension—Niacin—coronary artery disease	0.00111	0.00551	CcSEcCtD
Cyclopentolate—Ataxia—Captopril—coronary artery disease	0.00109	0.00544	CcSEcCtD
Cyclopentolate—Flushing—Acetylsalicylic acid—coronary artery disease	0.00109	0.00543	CcSEcCtD
Cyclopentolate—Abdominal distension—Pravastatin—coronary artery disease	0.00109	0.00542	CcSEcCtD
Cyclopentolate—Vertigo—Gemfibrozil—coronary artery disease	0.00107	0.00535	CcSEcCtD
Cyclopentolate—Urinary retention—Perindopril—coronary artery disease	0.00107	0.00534	CcSEcCtD
Cyclopentolate—Photophobia—Lisinopril—coronary artery disease	0.00106	0.0053	CcSEcCtD
Cyclopentolate—Abdominal distension—Trandolapril—coronary artery disease	0.00106	0.00527	CcSEcCtD
Cyclopentolate—Vertigo—Ticagrelor—coronary artery disease	0.00105	0.00523	CcSEcCtD
Cyclopentolate—Urinary retention—Furosemide—coronary artery disease	0.00104	0.00519	CcSEcCtD
Cyclopentolate—Abdominal distension—Telmisartan—coronary artery disease	0.00104	0.00517	CcSEcCtD
Cyclopentolate—Convulsion—Gemfibrozil—coronary artery disease	0.00104	0.00516	CcSEcCtD
Cyclopentolate—Hallucination—Clopidogrel—coronary artery disease	0.00103	0.00511	CcSEcCtD
Cyclopentolate—Gastroenteritis—Ramipril—coronary artery disease	0.00102	0.00509	CcSEcCtD
Cyclopentolate—Ataxia—Losartan—coronary artery disease	0.000994	0.00495	CcSEcCtD
Cyclopentolate—Disorientation—Timolol—coronary artery disease	0.000991	0.00493	CcSEcCtD
Cyclopentolate—Pruritus—Pitavastatin—coronary artery disease	0.000975	0.00486	CcSEcCtD
Cyclopentolate—Abdominal distension—Furosemide—coronary artery disease	0.000954	0.00475	CcSEcCtD
Cyclopentolate—Flushing—Lovastatin—coronary artery disease	0.00095	0.00473	CcSEcCtD
Cyclopentolate—Agitation—Acetylsalicylic acid—coronary artery disease	0.000939	0.00468	CcSEcCtD
Cyclopentolate—Drowsiness—Trandolapril—coronary artery disease	0.000937	0.00466	CcSEcCtD
Cyclopentolate—Flushing—Ezetimibe—coronary artery disease	0.000932	0.00464	CcSEcCtD
Cyclopentolate—Gastroenteritis—Lisinopril—coronary artery disease	0.000928	0.00462	CcSEcCtD
Cyclopentolate—Vertigo—Acetylsalicylic acid—coronary artery disease	0.000918	0.00457	CcSEcCtD
Cyclopentolate—Flushing—Eplerenone—coronary artery disease	0.000912	0.00454	CcSEcCtD
Cyclopentolate—Conjunctivitis—Enalapril—coronary artery disease	0.000907	0.00452	CcSEcCtD
Cyclopentolate—Conjunctivitis—Telmisartan—coronary artery disease	0.000895	0.00445	CcSEcCtD
Cyclopentolate—Flushing—Simvastatin—coronary artery disease	0.000889	0.00443	CcSEcCtD
Cyclopentolate—Convulsion—Acetylsalicylic acid—coronary artery disease	0.000885	0.00441	CcSEcCtD
Cyclopentolate—Rash—Pitavastatin—coronary artery disease	0.000869	0.00433	CcSEcCtD
Cyclopentolate—Drowsiness—Perindopril—coronary artery disease	0.000869	0.00433	CcSEcCtD
Cyclopentolate—Dermatitis—Pitavastatin—coronary artery disease	0.000868	0.00432	CcSEcCtD
Cyclopentolate—Somnolence—Gemfibrozil—coronary artery disease	0.000868	0.00432	CcSEcCtD
Cyclopentolate—Drowsiness—Furosemide—coronary artery disease	0.000845	0.00421	CcSEcCtD
Cyclopentolate—Conjunctivitis—Perindopril—coronary artery disease	0.000845	0.00421	CcSEcCtD
Cyclopentolate—Vision blurred—Lovastatin—coronary artery disease	0.00084	0.00418	CcSEcCtD
Cyclopentolate—Hallucination—Trandolapril—coronary artery disease	0.000837	0.00417	CcSEcCtD
Cyclopentolate—Tremor—Lovastatin—coronary artery disease	0.000835	0.00416	CcSEcCtD
Cyclopentolate—Vertigo—Fenofibrate—coronary artery disease	0.00082	0.00408	CcSEcCtD
Cyclopentolate—Flushing—Niacin—coronary artery disease	0.000816	0.00406	CcSEcCtD
Cyclopentolate—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.000814	0.00405	CcSEcCtD
Cyclopentolate—Vertigo—Clopidogrel—coronary artery disease	0.000806	0.00402	CcSEcCtD
Cyclopentolate—Flushing—Pravastatin—coronary artery disease	0.000804	0.004	CcSEcCtD
Cyclopentolate—Vertigo—Lovastatin—coronary artery disease	0.000801	0.00399	CcSEcCtD
Cyclopentolate—Hallucination—Captopril—coronary artery disease	0.000799	0.00398	CcSEcCtD
Cyclopentolate—Conjunctivitis—Losartan—coronary artery disease	0.000792	0.00394	CcSEcCtD
Cyclopentolate—Vision blurred—Simvastatin—coronary artery disease	0.000786	0.00391	CcSEcCtD
Cyclopentolate—Tremor—Simvastatin—coronary artery disease	0.000781	0.00389	CcSEcCtD
Cyclopentolate—Flushing—Trandolapril—coronary artery disease	0.000781	0.00389	CcSEcCtD
Cyclopentolate—Flushing—Enalapril—coronary artery disease	0.000777	0.00387	CcSEcCtD
Cyclopentolate—Hallucination—Perindopril—coronary artery disease	0.000776	0.00386	CcSEcCtD
Cyclopentolate—Ataxia—Lisinopril—coronary artery disease	0.000773	0.00385	CcSEcCtD
Cyclopentolate—Flushing—Telmisartan—coronary artery disease	0.000767	0.00382	CcSEcCtD
Cyclopentolate—Dry mouth—Fenofibrate—coronary artery disease	0.00076	0.00379	CcSEcCtD
Cyclopentolate—Vertigo—Simvastatin—coronary artery disease	0.000749	0.00373	CcSEcCtD
Cyclopentolate—Flushing—Captopril—coronary artery disease	0.000746	0.00371	CcSEcCtD
Cyclopentolate—Dry mouth—Lovastatin—coronary artery disease	0.000742	0.0037	CcSEcCtD
Cyclopentolate—Vision blurred—Valsartan—coronary artery disease	0.000742	0.0037	CcSEcCtD
Cyclopentolate—Somnolence—Acetylsalicylic acid—coronary artery disease	0.000742	0.00369	CcSEcCtD
Cyclopentolate—Vision blurred—Olmesartan—coronary artery disease	0.000739	0.00368	CcSEcCtD
Cyclopentolate—Dry mouth—Ezetimibe—coronary artery disease	0.000728	0.00363	CcSEcCtD
Cyclopentolate—Tachycardia—Fenofibrate—coronary artery disease	0.000727	0.00362	CcSEcCtD
Cyclopentolate—Flushing—Perindopril—coronary artery disease	0.000724	0.0036	CcSEcCtD
Cyclopentolate—Vision blurred—Niacin—coronary artery disease	0.000722	0.00359	CcSEcCtD
Cyclopentolate—Agitation—Olmesartan—coronary artery disease	0.00072	0.00359	CcSEcCtD
Cyclopentolate—Vision blurred—Pravastatin—coronary artery disease	0.000711	0.00354	CcSEcCtD
Cyclopentolate—Vertigo—Valsartan—coronary artery disease	0.000708	0.00352	CcSEcCtD
Cyclopentolate—Tremor—Pravastatin—coronary artery disease	0.000706	0.00352	CcSEcCtD
Cyclopentolate—Vertigo—Olmesartan—coronary artery disease	0.000704	0.00351	CcSEcCtD
Cyclopentolate—Pruritus—Gemfibrozil—coronary artery disease	0.000691	0.00344	CcSEcCtD
Cyclopentolate—Vertigo—Niacin—coronary artery disease	0.000688	0.00343	CcSEcCtD
Cyclopentolate—Vision blurred—Enalapril—coronary artery disease	0.000687	0.00342	CcSEcCtD
Cyclopentolate—Tremor—Enalapril—coronary artery disease	0.000683	0.0034	CcSEcCtD
Cyclopentolate—Conjunctivitis—Ramipril—coronary artery disease	0.000679	0.00338	CcSEcCtD
Cyclopentolate—Flushing—Losartan—coronary artery disease	0.000679	0.00338	CcSEcCtD
Cyclopentolate—Vertigo—Pravastatin—coronary artery disease	0.000677	0.00337	CcSEcCtD
Cyclopentolate—Pruritus—Ticagrelor—coronary artery disease	0.000675	0.00336	CcSEcCtD
Cyclopentolate—Agitation—Trandolapril—coronary artery disease	0.000673	0.00335	CcSEcCtD
Cyclopentolate—Agitation—Enalapril—coronary artery disease	0.00067	0.00334	CcSEcCtD
Cyclopentolate—Conjunctivitis—Timolol—coronary artery disease	0.000664	0.00331	CcSEcCtD
Cyclopentolate—Somnolence—Fenofibrate—coronary artery disease	0.000662	0.0033	CcSEcCtD
Cyclopentolate—Vision blurred—Captopril—coronary artery disease	0.000659	0.00328	CcSEcCtD
Cyclopentolate—Vertigo—Trandolapril—coronary artery disease	0.000658	0.00328	CcSEcCtD
Cyclopentolate—Dry mouth—Valsartan—coronary artery disease	0.000656	0.00326	CcSEcCtD
Cyclopentolate—Vertigo—Enalapril—coronary artery disease	0.000655	0.00326	CcSEcCtD
Cyclopentolate—Vertigo—Telmisartan—coronary artery disease	0.000646	0.00322	CcSEcCtD
Cyclopentolate—Dry mouth—Niacin—coronary artery disease	0.000638	0.00317	CcSEcCtD
Cyclopentolate—Tremor—Perindopril—coronary artery disease	0.000636	0.00317	CcSEcCtD
Cyclopentolate—Tachycardia—Olmesartan—coronary artery disease	0.000624	0.00311	CcSEcCtD
Cyclopentolate—Agitation—Perindopril—coronary artery disease	0.000624	0.00311	CcSEcCtD
Cyclopentolate—Vision blurred—Furosemide—coronary artery disease	0.000622	0.0031	CcSEcCtD
Cyclopentolate—Rash—Gemfibrozil—coronary artery disease	0.000616	0.00307	CcSEcCtD
Cyclopentolate—Dermatitis—Gemfibrozil—coronary artery disease	0.000615	0.00306	CcSEcCtD
Cyclopentolate—Hallucination—Timolol—coronary artery disease	0.00061	0.00304	CcSEcCtD
Cyclopentolate—Vertigo—Perindopril—coronary artery disease	0.00061	0.00304	CcSEcCtD
Cyclopentolate—Tachycardia—Niacin—coronary artery disease	0.00061	0.00304	CcSEcCtD
Cyclopentolate—Dry mouth—Trandolapril—coronary artery disease	0.00061	0.00304	CcSEcCtD
Cyclopentolate—Pruritus—Rosuvastatin—coronary artery disease	0.000607	0.00302	CcSEcCtD
Cyclopentolate—Dry mouth—Enalapril—coronary artery disease	0.000607	0.00302	CcSEcCtD
Cyclopentolate—Agitation—Furosemide—coronary artery disease	0.000607	0.00302	CcSEcCtD
Cyclopentolate—Rash—Ticagrelor—coronary artery disease	0.000601	0.00299	CcSEcCtD
Cyclopentolate—Dermatitis—Ticagrelor—coronary artery disease	0.000601	0.00299	CcSEcCtD
Cyclopentolate—Vision blurred—Losartan—coronary artery disease	0.0006	0.00299	CcSEcCtD
Cyclopentolate—Dry mouth—Telmisartan—coronary artery disease	0.000599	0.00298	CcSEcCtD
Cyclopentolate—Tremor—Losartan—coronary artery disease	0.000597	0.00297	CcSEcCtD
Cyclopentolate—Vertigo—Furosemide—coronary artery disease	0.000593	0.00295	CcSEcCtD
Cyclopentolate—Pruritus—Acetylsalicylic acid—coronary artery disease	0.00059	0.00294	CcSEcCtD
Cyclopentolate—Agitation—Losartan—coronary artery disease	0.000585	0.00291	CcSEcCtD
Cyclopentolate—Tachycardia—Trandolapril—coronary artery disease	0.000583	0.0029	CcSEcCtD
Cyclopentolate—Dry mouth—Captopril—coronary artery disease	0.000582	0.0029	CcSEcCtD
Cyclopentolate—Flushing—Ramipril—coronary artery disease	0.000582	0.0029	CcSEcCtD
Cyclopentolate—Tachycardia—Enalapril—coronary artery disease	0.000581	0.00289	CcSEcCtD
Cyclopentolate—Tachycardia—Telmisartan—coronary artery disease	0.000573	0.00285	CcSEcCtD
Cyclopentolate—Vertigo—Losartan—coronary artery disease	0.000572	0.00285	CcSEcCtD
Cyclopentolate—Somnolence—Valsartan—coronary artery disease	0.000571	0.00285	CcSEcCtD
Cyclopentolate—Hallucination—Lisinopril—coronary artery disease	0.000566	0.00282	CcSEcCtD
Cyclopentolate—Dry mouth—Perindopril—coronary artery disease	0.000565	0.00282	CcSEcCtD
Cyclopentolate—Tachycardia—Captopril—coronary artery disease	0.000557	0.00277	CcSEcCtD
Cyclopentolate—Somnolence—Niacin—coronary artery disease	0.000556	0.00277	CcSEcCtD
Cyclopentolate—Dry mouth—Furosemide—coronary artery disease	0.00055	0.00274	CcSEcCtD
Cyclopentolate—Rash—Rosuvastatin—coronary artery disease	0.000541	0.0027	CcSEcCtD
Cyclopentolate—Tachycardia—Perindopril—coronary artery disease	0.000541	0.00269	CcSEcCtD
Cyclopentolate—Dermatitis—Rosuvastatin—coronary artery disease	0.000541	0.00269	CcSEcCtD
Cyclopentolate—Somnolence—Trandolapril—coronary artery disease	0.000531	0.00264	CcSEcCtD
Cyclopentolate—Dry mouth—Losartan—coronary artery disease	0.00053	0.00264	CcSEcCtD
Cyclopentolate—Somnolence—Enalapril—coronary artery disease	0.000529	0.00263	CcSEcCtD
Cyclopentolate—Flushing—Lisinopril—coronary artery disease	0.000528	0.00263	CcSEcCtD
Cyclopentolate—Pruritus—Fenofibrate—coronary artery disease	0.000527	0.00263	CcSEcCtD
Cyclopentolate—Rash—Acetylsalicylic acid—coronary artery disease	0.000526	0.00262	CcSEcCtD
Cyclopentolate—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000525	0.00262	CcSEcCtD
Cyclopentolate—Somnolence—Telmisartan—coronary artery disease	0.000522	0.0026	CcSEcCtD
Cyclopentolate—Pruritus—Clopidogrel—coronary artery disease	0.000518	0.00258	CcSEcCtD
Cyclopentolate—Pruritus—Lovastatin—coronary artery disease	0.000515	0.00256	CcSEcCtD
Cyclopentolate—Tremor—Ramipril—coronary artery disease	0.000512	0.00255	CcSEcCtD
Cyclopentolate—Somnolence—Captopril—coronary artery disease	0.000507	0.00253	CcSEcCtD
Cyclopentolate—Tachycardia—Losartan—coronary artery disease	0.000507	0.00253	CcSEcCtD
Cyclopentolate—Pruritus—Ezetimibe—coronary artery disease	0.000505	0.00251	CcSEcCtD
Cyclopentolate—Vision blurred—Timolol—coronary artery disease	0.000503	0.00251	CcSEcCtD
Cyclopentolate—Agitation—Ramipril—coronary artery disease	0.000502	0.0025	CcSEcCtD
Cyclopentolate—Pruritus—Eplerenone—coronary artery disease	0.000494	0.00246	CcSEcCtD
Cyclopentolate—Somnolence—Perindopril—coronary artery disease	0.000493	0.00245	CcSEcCtD
Cyclopentolate—Vertigo—Ramipril—coronary artery disease	0.000491	0.00244	CcSEcCtD
Cyclopentolate—Pruritus—Simvastatin—coronary artery disease	0.000482	0.0024	CcSEcCtD
Cyclopentolate—Vertigo—Timolol—coronary artery disease	0.00048	0.00239	CcSEcCtD
Cyclopentolate—Somnolence—Furosemide—coronary artery disease	0.000479	0.00238	CcSEcCtD
Cyclopentolate—Convulsion—Ramipril—coronary artery disease	0.000473	0.00236	CcSEcCtD
Cyclopentolate—Rash—Fenofibrate—coronary artery disease	0.00047	0.00234	CcSEcCtD
Cyclopentolate—Dermatitis—Fenofibrate—coronary artery disease	0.000469	0.00234	CcSEcCtD
Cyclopentolate—Vision blurred—Lisinopril—coronary artery disease	0.000467	0.00232	CcSEcCtD
Cyclopentolate—Tremor—Lisinopril—coronary artery disease	0.000464	0.00231	CcSEcCtD
Cyclopentolate—Somnolence—Losartan—coronary artery disease	0.000462	0.0023	CcSEcCtD
Cyclopentolate—Rash—Clopidogrel—coronary artery disease	0.000462	0.0023	CcSEcCtD
Cyclopentolate—Dermatitis—Clopidogrel—coronary artery disease	0.000461	0.0023	CcSEcCtD
Cyclopentolate—Rash—Lovastatin—coronary artery disease	0.000459	0.00228	CcSEcCtD
Cyclopentolate—Dermatitis—Lovastatin—coronary artery disease	0.000458	0.00228	CcSEcCtD
Cyclopentolate—Pruritus—Valsartan—coronary artery disease	0.000455	0.00226	CcSEcCtD
Cyclopentolate—Dry mouth—Ramipril—coronary artery disease	0.000455	0.00226	CcSEcCtD
Cyclopentolate—Pruritus—Olmesartan—coronary artery disease	0.000453	0.00225	CcSEcCtD
Cyclopentolate—Rash—Ezetimibe—coronary artery disease	0.00045	0.00224	CcSEcCtD
Cyclopentolate—Dermatitis—Ezetimibe—coronary artery disease	0.00045	0.00224	CcSEcCtD
Cyclopentolate—Vertigo—Lisinopril—coronary artery disease	0.000445	0.00222	CcSEcCtD
Cyclopentolate—Dry mouth—Timolol—coronary artery disease	0.000445	0.00221	CcSEcCtD
Cyclopentolate—Pruritus—Niacin—coronary artery disease	0.000442	0.0022	CcSEcCtD
Cyclopentolate—Rash—Eplerenone—coronary artery disease	0.00044	0.00219	CcSEcCtD
Cyclopentolate—Dermatitis—Eplerenone—coronary artery disease	0.00044	0.00219	CcSEcCtD
Cyclopentolate—Pruritus—Pravastatin—coronary artery disease	0.000435	0.00217	CcSEcCtD
Cyclopentolate—Tachycardia—Ramipril—coronary artery disease	0.000435	0.00217	CcSEcCtD
Cyclopentolate—Rash—Simvastatin—coronary artery disease	0.000429	0.00214	CcSEcCtD
Cyclopentolate—Dermatitis—Simvastatin—coronary artery disease	0.000429	0.00213	CcSEcCtD
Cyclopentolate—Pruritus—Trandolapril—coronary artery disease	0.000423	0.0021	CcSEcCtD
Cyclopentolate—Pruritus—Enalapril—coronary artery disease	0.000421	0.0021	CcSEcCtD
Cyclopentolate—Pruritus—Telmisartan—coronary artery disease	0.000415	0.00207	CcSEcCtD
Cyclopentolate—Dry mouth—Lisinopril—coronary artery disease	0.000412	0.00205	CcSEcCtD
Cyclopentolate—Rash—Valsartan—coronary artery disease	0.000405	0.00202	CcSEcCtD
Cyclopentolate—Dermatitis—Valsartan—coronary artery disease	0.000405	0.00202	CcSEcCtD
Cyclopentolate—Pruritus—Captopril—coronary artery disease	0.000404	0.00201	CcSEcCtD
Cyclopentolate—Rash—Olmesartan—coronary artery disease	0.000403	0.00201	CcSEcCtD
Cyclopentolate—Dermatitis—Olmesartan—coronary artery disease	0.000403	0.00201	CcSEcCtD
Cyclopentolate—Somnolence—Ramipril—coronary artery disease	0.000396	0.00197	CcSEcCtD
Cyclopentolate—Tachycardia—Lisinopril—coronary artery disease	0.000395	0.00196	CcSEcCtD
Cyclopentolate—Rash—Niacin—coronary artery disease	0.000394	0.00196	CcSEcCtD
Cyclopentolate—Dermatitis—Niacin—coronary artery disease	0.000394	0.00196	CcSEcCtD
Cyclopentolate—Pruritus—Perindopril—coronary artery disease	0.000392	0.00195	CcSEcCtD
Cyclopentolate—Rash—Pravastatin—coronary artery disease	0.000388	0.00193	CcSEcCtD
Cyclopentolate—Dermatitis—Pravastatin—coronary artery disease	0.000388	0.00193	CcSEcCtD
Cyclopentolate—Somnolence—Timolol—coronary artery disease	0.000387	0.00193	CcSEcCtD
Cyclopentolate—Pruritus—Furosemide—coronary artery disease	0.000381	0.0019	CcSEcCtD
Cyclopentolate—Rash—Trandolapril—coronary artery disease	0.000377	0.00188	CcSEcCtD
Cyclopentolate—Dermatitis—Trandolapril—coronary artery disease	0.000376	0.00187	CcSEcCtD
Cyclopentolate—Rash—Enalapril—coronary artery disease	0.000375	0.00187	CcSEcCtD
Cyclopentolate—Dermatitis—Enalapril—coronary artery disease	0.000375	0.00187	CcSEcCtD
Cyclopentolate—Rash—Telmisartan—coronary artery disease	0.00037	0.00184	CcSEcCtD
Cyclopentolate—Dermatitis—Telmisartan—coronary artery disease	0.00037	0.00184	CcSEcCtD
Cyclopentolate—Pruritus—Losartan—coronary artery disease	0.000368	0.00183	CcSEcCtD
Cyclopentolate—Venlafaxine—CYP2C19—coronary artery disease	0.000366	0.478	CrCbGaD
Cyclopentolate—Rash—Captopril—coronary artery disease	0.00036	0.00179	CcSEcCtD
Cyclopentolate—Dermatitis—Captopril—coronary artery disease	0.00036	0.00179	CcSEcCtD
Cyclopentolate—Somnolence—Lisinopril—coronary artery disease	0.000359	0.00179	CcSEcCtD
Cyclopentolate—Rash—Perindopril—coronary artery disease	0.000349	0.00174	CcSEcCtD
Cyclopentolate—Dermatitis—Perindopril—coronary artery disease	0.000349	0.00174	CcSEcCtD
Cyclopentolate—Rash—Furosemide—coronary artery disease	0.00034	0.00169	CcSEcCtD
Cyclopentolate—Dermatitis—Furosemide—coronary artery disease	0.000339	0.00169	CcSEcCtD
Cyclopentolate—Rash—Losartan—coronary artery disease	0.000328	0.00163	CcSEcCtD
Cyclopentolate—Dermatitis—Losartan—coronary artery disease	0.000327	0.00163	CcSEcCtD
Cyclopentolate—Pruritus—Ramipril—coronary artery disease	0.000315	0.00157	CcSEcCtD
Cyclopentolate—Pruritus—Timolol—coronary artery disease	0.000308	0.00154	CcSEcCtD
Cyclopentolate—Pruritus—Lisinopril—coronary artery disease	0.000286	0.00142	CcSEcCtD
Cyclopentolate—Rash—Ramipril—coronary artery disease	0.000281	0.0014	CcSEcCtD
Cyclopentolate—Dermatitis—Ramipril—coronary artery disease	0.000281	0.0014	CcSEcCtD
Cyclopentolate—Rash—Timolol—coronary artery disease	0.000275	0.00137	CcSEcCtD
Cyclopentolate—Dermatitis—Timolol—coronary artery disease	0.000274	0.00137	CcSEcCtD
Cyclopentolate—Rash—Lisinopril—coronary artery disease	0.000255	0.00127	CcSEcCtD
Cyclopentolate—Dermatitis—Lisinopril—coronary artery disease	0.000255	0.00127	CcSEcCtD
Cyclopentolate—Pethidine—CYP2C19—coronary artery disease	0.000187	0.245	CrCbGaD
Cyclopentolate—Diphenhydramine—CYP2C19—coronary artery disease	0.000108	0.141	CrCbGaD
Cyclopentolate—Pethidine—ALB—coronary artery disease	0.000104	0.136	CrCbGaD
Cyclopentolate—CHRM1—Signaling Pathways—LDLR—coronary artery disease	2.87e-05	0.000179	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LDLR—coronary artery disease	2.86e-05	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AGT—coronary artery disease	2.83e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AGT—coronary artery disease	2.82e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PPP2CA—coronary artery disease	2.82e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PPP2CA—coronary artery disease	2.81e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL3—coronary artery disease	2.8e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL2—coronary artery disease	2.8e-05	0.000175	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTM1—coronary artery disease	2.8e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL3—coronary artery disease	2.8e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL2—coronary artery disease	2.8e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PLCB1—coronary artery disease	2.78e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SDC1—coronary artery disease	2.77e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—F2R—coronary artery disease	2.77e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCD—coronary artery disease	2.77e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—F2R—coronary artery disease	2.76e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SDC1—coronary artery disease	2.76e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCD—coronary artery disease	2.76e-05	0.000172	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—LPL—coronary artery disease	2.75e-05	0.000171	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGB—coronary artery disease	2.71e-05	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR2A—coronary artery disease	2.71e-05	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGB—coronary artery disease	2.71e-05	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—C3—coronary artery disease	2.7e-05	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR2A—coronary artery disease	2.7e-05	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—C3—coronary artery disease	2.7e-05	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCA1—coronary artery disease	2.7e-05	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDNRB—coronary artery disease	2.69e-05	0.000167	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GPX1—coronary artery disease	2.68e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDNRB—coronary artery disease	2.68e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—THBS1—coronary artery disease	2.65e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—THBS1—coronary artery disease	2.64e-05	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PSMA6—coronary artery disease	2.62e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PSMB5—coronary artery disease	2.62e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—F2—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CD36—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PSMA6—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PSMB5—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GOT1—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GGT1—coronary artery disease	2.61e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—F2—coronary artery disease	2.61e-05	0.000162	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPP2CA—coronary artery disease	2.58e-05	0.000161	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AGT—coronary artery disease	2.57e-05	0.00016	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AGT—coronary artery disease	2.56e-05	0.000159	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDNRA—coronary artery disease	2.54e-05	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDNRA—coronary artery disease	2.53e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CYBA—coronary artery disease	2.53e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRB1—coronary artery disease	2.53e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CYBA—coronary artery disease	2.52e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRB1—coronary artery disease	2.52e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DUSP6—coronary artery disease	2.51e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DUSP6—coronary artery disease	2.51e-05	0.000156	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MTHFR—coronary artery disease	2.48e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLAT—coronary artery disease	2.47e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLAT—coronary artery disease	2.46e-05	0.000153	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BDKRB2—coronary artery disease	2.38e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL12—coronary artery disease	2.38e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—POMC—coronary artery disease	2.38e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL12—coronary artery disease	2.38e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BDKRB2—coronary artery disease	2.38e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—F2—coronary artery disease	2.37e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—POMC—coronary artery disease	2.37e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—F2—coronary artery disease	2.37e-05	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6ST—coronary artery disease	2.36e-05	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6ST—coronary artery disease	2.36e-05	0.000147	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AGT—coronary artery disease	2.35e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTP1—coronary artery disease	2.34e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUNB—coronary artery disease	2.34e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUNB—coronary artery disease	2.33e-05	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	2.33e-05	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	2.33e-05	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARGC1A—coronary artery disease	2.32e-05	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—coronary artery disease	2.31e-05	0.000144	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—coronary artery disease	2.31e-05	0.000144	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR7—coronary artery disease	2.28e-05	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAT—coronary artery disease	2.28e-05	0.000142	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOA1—coronary artery disease	2.28e-05	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR7—coronary artery disease	2.28e-05	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOB—coronary artery disease	2.22e-05	0.000138	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.18e-05	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	2.18e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KNG1—coronary artery disease	2.17e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	2.17e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KNG1—coronary artery disease	2.16e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—POMC—coronary artery disease	2.16e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	2.16e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	2.16e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—POMC—coronary artery disease	2.16e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	2.16e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—coronary artery disease	2.15e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	2.15e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	2.12e-05	0.000132	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—LPL—coronary artery disease	2.12e-05	0.000132	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	2.11e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	2.11e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	2.11e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	2.1e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLG—coronary artery disease	2.1e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	2.1e-05	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLG—coronary artery disease	2.1e-05	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—coronary artery disease	2.06e-05	0.000128	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	2.05e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	2.04e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	2.02e-05	0.000126	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	2.02e-05	0.000126	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	2.02e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—S100B—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CD36—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—coronary artery disease	2.01e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—S100B—coronary artery disease	2e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	1.99e-05	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPP2CA—coronary artery disease	1.98e-05	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	1.98e-05	0.000124	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—POMC—coronary artery disease	1.98e-05	0.000123	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	1.97e-05	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KITLG—coronary artery disease	1.97e-05	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KITLG—coronary artery disease	1.96e-05	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	1.96e-05	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	1.92e-05	0.00012	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP3—coronary artery disease	1.92e-05	0.00012	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	1.92e-05	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP3—coronary artery disease	1.92e-05	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—coronary artery disease	1.9e-05	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOB—coronary artery disease	1.86e-05	0.000116	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOB—coronary artery disease	1.85e-05	0.000115	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	1.84e-05	0.000115	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	1.84e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	1.83e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDN1—coronary artery disease	1.83e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	1.83e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDN1—coronary artery disease	1.82e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL5—coronary artery disease	1.81e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AGT—coronary artery disease	1.81e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL5—coronary artery disease	1.81e-05	0.000113	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—coronary artery disease	1.81e-05	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CSF2—coronary artery disease	1.79e-05	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF1—coronary artery disease	1.79e-05	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CSF2—coronary artery disease	1.78e-05	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF1—coronary artery disease	1.78e-05	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LPL—coronary artery disease	1.77e-05	0.00011	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—coronary artery disease	1.77e-05	0.00011	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LPL—coronary artery disease	1.77e-05	0.00011	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	1.76e-05	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	1.76e-05	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	1.75e-05	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	1.75e-05	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOA1—coronary artery disease	1.75e-05	0.000109	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—coronary artery disease	1.73e-05	0.000108	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	1.71e-05	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	1.71e-05	0.000106	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	1.67e-05	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	1.67e-05	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	1.66e-05	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	1.66e-05	0.000103	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	1.63e-05	0.000102	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	1.63e-05	0.000101	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	1.6e-05	9.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—C3—coronary artery disease	1.6e-05	9.94e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	1.59e-05	9.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—C3—coronary artery disease	1.59e-05	9.91e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—coronary artery disease	1.58e-05	9.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—coronary artery disease	1.54e-05	9.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	1.52e-05	9.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—POMC—coronary artery disease	1.52e-05	9.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	1.52e-05	9.45e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGT—coronary artery disease	1.52e-05	9.45e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGT—coronary artery disease	1.51e-05	9.42e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—coronary artery disease	1.49e-05	9.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LEP—coronary artery disease	1.49e-05	9.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LEP—coronary artery disease	1.48e-05	9.23e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—coronary artery disease	1.48e-05	9.23e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOA1—coronary artery disease	1.47e-05	9.15e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOA1—coronary artery disease	1.47e-05	9.12e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—coronary artery disease	1.46e-05	9.07e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—coronary artery disease	1.45e-05	9.04e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	1.45e-05	9.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	1.44e-05	8.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ESR1—coronary artery disease	1.42e-05	8.84e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ESR1—coronary artery disease	1.42e-05	8.81e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—F2—coronary artery disease	1.4e-05	8.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FN1—coronary artery disease	1.4e-05	8.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—F2—coronary artery disease	1.4e-05	8.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FN1—coronary artery disease	1.4e-05	8.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	1.4e-05	8.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	1.39e-05	8.67e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—coronary artery disease	1.39e-05	8.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	1.39e-05	8.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	1.38e-05	8.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KIT—coronary artery disease	1.34e-05	8.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KIT—coronary artery disease	1.34e-05	8.33e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—coronary artery disease	1.33e-05	8.27e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	1.29e-05	8.02e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	1.28e-05	7.99e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—POMC—coronary artery disease	1.28e-05	7.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CREB1—coronary artery disease	1.28e-05	7.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—POMC—coronary artery disease	1.27e-05	7.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CREB1—coronary artery disease	1.27e-05	7.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.25e-05	7.78e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.25e-05	7.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL2—coronary artery disease	1.25e-05	7.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6R—coronary artery disease	1.24e-05	7.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.23e-05	7.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1—coronary artery disease	1.22e-05	7.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.22e-05	7.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	1.22e-05	7.59e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—coronary artery disease	1.21e-05	7.56e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.17e-05	7.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.17e-05	7.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.16e-05	7.25e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	1.16e-05	7.24e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.13e-05	7.03e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.13e-05	7.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.11e-05	6.94e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.11e-05	6.91e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.08e-05	6.74e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.08e-05	6.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.06e-05	6.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.06e-05	6.59e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	9.88e-06	6.15e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	9.85e-06	6.13e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CA—coronary artery disease	9.72e-06	6.05e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	9.55e-06	5.94e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	9.52e-06	5.92e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—coronary artery disease	9.46e-06	5.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—coronary artery disease	9.43e-06	5.87e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—coronary artery disease	9.4e-06	5.85e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—coronary artery disease	9.37e-06	5.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCND1—coronary artery disease	9.21e-06	5.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCND1—coronary artery disease	9.18e-06	5.71e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—coronary artery disease	8.94e-06	5.56e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—coronary artery disease	8.91e-06	5.55e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	8.67e-06	5.4e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	8.64e-06	5.38e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	8.03e-06	5e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	8e-06	4.98e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—coronary artery disease	7.94e-06	4.94e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CA—coronary artery disease	7.47e-06	4.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	7.37e-06	4.59e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	7.34e-06	4.57e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	7.22e-06	4.5e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	7.2e-06	4.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	6.27e-06	3.9e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	6.25e-06	3.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—coronary artery disease	6.11e-06	3.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—coronary artery disease	5.55e-06	3.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—coronary artery disease	5.53e-06	3.45e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—coronary artery disease	5.12e-06	3.19e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—coronary artery disease	5.11e-06	3.18e-05	CbGpPWpGaD
